<DOC>
	<DOCNO>NCT02772133</DOCNO>
	<brief_summary>Purpose : The purpose study evaluate impact acute ST-segment elevation myocardial infarction ( STEMI ) primary percutaneous coronary intervention ( PCI ) circulate prolylcarboxypeptidase ( PRCP ) level activity .</brief_summary>
	<brief_title>Circulating PRCP STEMI Patients Undergoing Primary PCI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Admitted primary PCI STEMI involve LAD within 12 hour onset symptom . STEMI define typical ECG change ( ST segment elevation ≥2mm 2 precordial lead ) associate acute chest pain elevation cardiac enzyme ; Age ≥18 year ; Informed consent subject next kin . Nonischaemic Cardiomyopathy ; Cardiac surgery plan 6 month ; Mechanical complication STEMI ( ventricular septal rupture , free wall rupture , acute severe mitral regurgitation ) ; Renal hepatic failure ; Malignancy , HIV , central nervous system disorder ; Cardiopulmonary resuscitation &gt; 15 min compromise level consciousness ; Cardiogenic shock ; Current participation research study involve investigational drug device ; No write consensus ; Previous myocardial infarction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>